European Commission allows Glycom A/S to place lacto-N-tetraose (‘LNT’), obtained by microbial fermentation with a genetically modified strain of Escherichia coli, strain K12 DH1, on the Union market as a novel food. CLICK HERE Tags: HMO, LNT, novel food Read more articles Previous PostFermented Food Consumption Associated with Changes in the Gut Microbiome Next PostThe Global Prebiotic Association Welcomes FrieslandCampina Ingredients as a New Member You Might Also Like Researchers Examine Prebiotic Supplementation in Kidney Transplant Patients to Mitigate infection and GI Upset April 5, 2022 Effect of Prebiotics on Gut Microbiome, Muscle Function and Cognition in Elderly Twin Cohort September 12, 2024 Cactus Pear Extract Shows Dual Action on Gut Health and Glucose Metabolism March 31, 2026
Researchers Examine Prebiotic Supplementation in Kidney Transplant Patients to Mitigate infection and GI Upset April 5, 2022
Effect of Prebiotics on Gut Microbiome, Muscle Function and Cognition in Elderly Twin Cohort September 12, 2024